RUBICON ORGANICS INC (ROMJ.CA) Fundamental Analysis & Valuation
TSX-V:ROMJ • CA78112W1005
Current stock price
0.55 CAD
+0.01 (+1.85%)
Last:
This ROMJ.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ROMJ.CA Profitability Analysis
1.1 Basic Checks
- In the past year ROMJ was profitable.
- ROMJ had a negative operating cash flow in the past year.
- In the past 5 years ROMJ reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: ROMJ reported negative operating cash flow in multiple years.
1.2 Ratios
- The Return On Assets of ROMJ (1.57%) is better than 77.42% of its industry peers.
- ROMJ has a better Return On Equity (2.39%) than 77.42% of its industry peers.
- ROMJ has a Return On Invested Capital of 21.47%. This is amongst the best in the industry. ROMJ outperforms 100.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ROMJ is significantly above the industry average of 8.64%.
- The 3 year average ROIC (20.40%) for ROMJ is below the current ROIC(21.47%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.57% | ||
| ROE | 2.39% | ||
| ROIC | 21.47% |
ROA(3y)-2.09%
ROA(5y)-7.93%
ROE(3y)-3.09%
ROE(5y)-11.33%
ROIC(3y)20.4%
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of ROMJ (1.77%) is better than 77.42% of its industry peers.
- Looking at the Operating Margin, with a value of 27.44%, ROMJ belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
- In the last couple of years the Operating Margin of ROMJ has declined.
- Looking at the Gross Margin, with a value of 61.61%, ROMJ belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
- ROMJ's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.44% | ||
| PM (TTM) | 1.77% | ||
| GM | 61.61% |
OM growth 3Y-7%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.44%
GM growth 5YN/A
2. ROMJ.CA Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ROMJ is creating value.
- The number of shares outstanding for ROMJ has been increased compared to 1 year ago.
- ROMJ has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for ROMJ is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.66, we must say that ROMJ is in the distress zone and has some risk of bankruptcy.
- ROMJ's Altman-Z score of 1.66 is fine compared to the rest of the industry. ROMJ outperforms 77.42% of its industry peers.
- ROMJ has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
- ROMJ has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.66 |
ROIC/WACC2.52
WACC8.51%
2.3 Liquidity
- ROMJ has a Current Ratio of 2.94. This indicates that ROMJ is financially healthy and has no problem in meeting its short term obligations.
- ROMJ has a Current ratio of 2.94. This is in the better half of the industry: ROMJ outperforms 74.19% of its industry peers.
- ROMJ has a Quick Ratio of 1.34. This is a normal value and indicates that ROMJ is financially healthy and should not expect problems in meeting its short term obligations.
- ROMJ has a Quick ratio (1.34) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.94 | ||
| Quick Ratio | 1.34 |
3. ROMJ.CA Growth Analysis
3.1 Past
- ROMJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 131.93%, which is quite impressive.
- ROMJ shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.08%.
- The Revenue has been growing by 44.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)131.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3862.5%
Revenue 1Y (TTM)22.08%
Revenue growth 3Y18.73%
Revenue growth 5Y44.65%
Sales Q2Q%15.92%
3.2 Future
- Based on estimates for the next years, ROMJ will show a very strong growth in Earnings Per Share. The EPS will grow by 72.61% on average per year.
- ROMJ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.69% yearly.
EPS Next Y14.27%
EPS Next 2Y69.02%
EPS Next 3Y72.61%
EPS Next 5YN/A
Revenue Next Year23.18%
Revenue Next 2Y19.79%
Revenue Next 3Y17.69%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. ROMJ.CA Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 55.00, ROMJ can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of ROMJ indicates a somewhat cheap valuation: ROMJ is cheaper than 67.74% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of ROMJ to the average of the S&P500 Index (27.42), we can say ROMJ is valued expensively.
- With a Price/Forward Earnings ratio of 10.21, the valuation of ROMJ can be described as very reasonable.
- ROMJ's Price/Forward Earnings ratio is rather cheap when compared to the industry. ROMJ is cheaper than 80.65% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ROMJ to the average of the S&P500 Index (22.24), we can say ROMJ is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55 | ||
| Fwd PE | 10.21 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ROMJ is valued cheaply inside the industry as 96.77% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.28 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ROMJ does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of ROMJ may justify a higher PE ratio.
- ROMJ's earnings are expected to grow with 72.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.85
PEG (5Y)N/A
EPS Next 2Y69.02%
EPS Next 3Y72.61%
5. ROMJ.CA Dividend Analysis
5.1 Amount
- No dividends for ROMJ!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ROMJ.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:ROMJ (4/24/2026, 7:00:00 PM)
0.55
+0.01 (+1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-24 2026-03-24/bmo
Earnings (Next)05-25 2026-05-25
Inst Owners3.34%
Inst Owner ChangeN/A
Ins Owners43.09%
Ins Owner ChangeN/A
Market Cap37.17M
Revenue(TTM)59.45M
Net Income(TTM)1.05M
Analysts82.86
Price Target1.17 (112.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)147.53%
Min EPS beat(2)-397.03%
Max EPS beat(2)692.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.28%
Min Revenue beat(2)-0.17%
Max Revenue beat(2)2.72%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-23.81%
EPS NY rev (3m)-23.81%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55 | ||
| Fwd PE | 10.21 | ||
| P/S | 0.63 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.84 | ||
| P/tB | 0.89 | ||
| EV/EBITDA | 2.28 |
EPS(TTM)0.01
EY1.82%
EPS(NY)0.05
Fwd EY9.79%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.88
BVpS0.65
TBVpS0.62
PEG (NY)3.85
PEG (5Y)N/A
Graham Number0.382992 (-30.37%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.57% | ||
| ROE | 2.39% | ||
| ROCE | 29.82% | ||
| ROIC | 21.47% | ||
| ROICexc | 23.16% | ||
| ROICexgc | 24.3% | ||
| OM | 27.44% | ||
| PM (TTM) | 1.77% | ||
| GM | 61.61% | ||
| FCFM | N/A |
ROA(3y)-2.09%
ROA(5y)-7.93%
ROE(3y)-3.09%
ROE(5y)-11.33%
ROIC(3y)20.4%
ROIC(5y)N/A
ROICexc(3y)25.1%
ROICexc(5y)N/A
ROICexgc(3y)26.91%
ROICexgc(5y)N/A
ROCE(3y)28.33%
ROCE(5y)N/A
ROICexgc growth 3Y1.06%
ROICexgc growth 5YN/A
ROICexc growth 3Y1.54%
ROICexc growth 5YN/A
OM growth 3Y-7%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.44%
GM growth 5YN/A
F-Score5
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 250.48% | ||
| Cap/Sales | 14.16% | ||
| Interest Coverage | 24.79 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.94 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.66 |
F-Score5
WACC8.51%
ROIC/WACC2.52
Cap/Depr(3y)128.41%
Cap/Depr(5y)152.11%
Cap/Sales(3y)8.05%
Cap/Sales(5y)12.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)131.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3862.5%
EPS Next Y14.27%
EPS Next 2Y69.02%
EPS Next 3Y72.61%
EPS Next 5YN/A
Revenue 1Y (TTM)22.08%
Revenue growth 3Y18.73%
Revenue growth 5Y44.65%
Sales Q2Q%15.92%
Revenue Next Year23.18%
Revenue Next 2Y19.79%
Revenue Next 3Y17.69%
Revenue Next 5YN/A
EBIT growth 1Y37.82%
EBIT growth 3Y10.42%
EBIT growth 5YN/A
EBIT Next Year170.38%
EBIT Next 3Y71%
EBIT Next 5YN/A
FCF growth 1Y-717.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-189.4%
OCF growth 3YN/A
OCF growth 5YN/A
RUBICON ORGANICS INC / ROMJ.CA Fundamental Analysis FAQ
What is the fundamental rating for ROMJ stock?
ChartMill assigns a fundamental rating of 5 / 10 to ROMJ.CA.
Can you provide the valuation status for RUBICON ORGANICS INC?
ChartMill assigns a valuation rating of 5 / 10 to RUBICON ORGANICS INC (ROMJ.CA). This can be considered as Fairly Valued.
How profitable is RUBICON ORGANICS INC (ROMJ.CA) stock?
RUBICON ORGANICS INC (ROMJ.CA) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for ROMJ stock?
The Price/Earnings (PE) ratio for RUBICON ORGANICS INC (ROMJ.CA) is 55 and the Price/Book (PB) ratio is 0.84.
Can you provide the expected EPS growth for ROMJ stock?
The Earnings per Share (EPS) of RUBICON ORGANICS INC (ROMJ.CA) is expected to grow by 14.27% in the next year.